-
Alternative_name
(E)-N-(3-((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)-4-(4-(dimethylamino)but-2-enamido)benzamide, hydrochloride
-
Description
THZ1 is a potent, cell-permeable, and selective covalent CDK7 inhibitor (IC₅₀ = 3.2 nM) that preferentially diminishes transcription in cancer cells. It displays unprecedented ability to target a remote cysteine residue located outside of the canonical kinase domain, providing an unanticipated means of achieving selectivity for CDK7.
-
CAS Number
1604810-83-4 (free base)
-
Structure Available
Yes
-
Salt Form
No
-
Molecular Formula
C₃₁H₂₉Cl₂N₇O₂
-
Molecular Weight
602.51
-
Cell Permeable
Yes
-
Purity
≥98% by HPLC
-
Solubilities
DMSO (>20 mg/ml)
-
Handling
Protect from air and light
-
Tag Line
A potent CDK7 inhibitor
-
Storage Condition
-20°C
-
Shipping Condition
gel pack
-
Shelf Life
36 months
-
PubChem CID
73602827
-
-
SMILES
O=C(NC1=CC=CC(NC2=NC=C(Cl)C(C3=CNC4=C3C=CC=C4)=N2)=C1)C5=CC=C(NC(/C=C/CN(C)C)=O)C=C5.[H]Cl
-
InChi
InChI=1S/C31H28ClN7O2.ClH/c1-39(2)16-6-11-28(40)35-21-14-12-20(13-15-21)30(41)36-22-7-5-8-23(17-22)37-31-34-19-26(32)29(38-31)25-18-33-27-10-4-3-9-24(25)27;/h3-15,17-19,33H,16H2,1-2H3,(H,35,40)(H,36,41)(H,34,37,38);1H/b11-6+;
-
InChi Key
LSAGMHUBJCPLJS-ICSBZGNSSA-N
-
-
MSDS Available
Yes